Lv1
70 积分 2024-04-17 加入
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
1个月前
已完结
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
1个月前
已完结
Durvalumab Plus Anlotinib Versus Durvalumab as Maintenance Treatment in ES-SCLC (DURABLE): A Randomized, Phase 2 Trial
4个月前
已关闭
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
5个月前
已关闭
肺癌免疫检查点抑制剂联合放疗中国专家共识(2025 版)
6个月前
已完结
局部治疗联合系统治疗对晚期胆道恶性肿瘤的疗效及安全性评估
6个月前
已完结
皖公网安备34019202002308
